Clinical Trials Logo

Overweight and Obesity clinical trials

View clinical trials related to Overweight and Obesity.

Filter by:

NCT ID: NCT04733053 Completed - Knee Osteoarthritis Clinical Trials

Effects of a Physiotherapist-delivered Dietary Weight Loss Program in People With Knee OA Who Have Overweight/Obesity

Start date: October 29, 2021
Phase: N/A
Study type: Interventional

The aim of this randomized controlled trial is to evaluate the effects of a physiotherapist-delivered dietary weight loss program on clinical outcomes among people with knee osteoarthritis (OA) who have overweight or obesity. The primary hypothesis is that a physiotherapist-delivered dietary weight loss plus exercise program will be more effective in achieving weight loss than a physiotherapist-delivered exercise program alone. Approximately 6-9 physiotherapists in Melbourne, Australia will be recruited and trained in weight management for OA patients, as well as trained in how to deliver the specific study interventions. The same therapists will deliver the intervention in both arms of the trial. 88 participants with knee OA will be recruited from the community and randomized into one of the two arms a) diet plus exercise intervention or b) exercise intervention alone. Participants in both groups will be asked to attend 6 consultations with the physiotherapist over 6 months. Questionnaire and laboratory-based outcome measures will be completed by participants at baseline and at the end of the 6 month intervention period. A biostatistician will analyse blinded, de-identified data.

NCT ID: NCT04721938 Completed - Infertility Clinical Trials

Healthy Parents - Healthy Children. Weight Loss Before Fertility Treatment

Start date: May 1, 2020
Phase: N/A
Study type: Interventional

The detrimental effect of overweight and obesity on fecundity has been well documented. The investigators wish to investigate the intervention program for weight loss before fertility treatment. Subsequently to gain knowledge on the effect of overweight/obesity and weight loss on the vaginal microbiome, on DNA damage on sperm cells, on the occurrence of endocrine disruptors in the endometrium, and on the gene expression in the endometrium.

NCT ID: NCT04701346 Completed - Clinical trials for Overweight and Obesity

Sulfur Amino Acids, Energy Metabolism and Obesity

STAY
Start date: March 1, 2021
Phase: N/A
Study type: Interventional

The primary objective of the trial is to establish the effects of dietary sulfur amino acid (SAA) restriction on body weight, body composition and energy expenditure in humans.

NCT ID: NCT04699448 Completed - Quality of Life Clinical Trials

Gene-diet Interactions on Body Weight Regulation and Lifestyle Parameters.

iMPROVE
Start date: April 13, 2020
Phase: N/A
Study type: Interventional

Increased body weight leading to the development and the establishment of overweight and obesity, has a growing detrimental effect on overall health status and quality of life. Latest research has been focusing on the direct influence of dietary habits on body weight regulation and its synergistic effect with genetic predisposition. The synergistic effect of genetic makeup and dietary habits constitute a major contributing factor, specifically in its manifestation on parameters of the cardiometabolic profile of individuals with elevated body weight. In this context, the aim of the present study is to investigate the effect of two hypocaloric diets with different macronutrient content (a high-carbohydrate/low-fat and a high-protein one) on the body weight loss of an overweight and/or obese adult, Greek population. Moreover, the study aims to explore gene-diet interactions between obesity and weight loss- related target genes and adherence to the proposed dietary schemes. It will further examine influences of the aforementioned factors on body composition, anthropometric indices, such as waist circumference, biochemical biomarkers related to cardiometabolic control and parameters of lifestyle, such as sleep quality. More specifically, 300 participants will be allocated into two groups, following either the high-carbohydrate/low-fat diet or the high-protein diet, for a duration of 3 months. Volunteers will participate in in-person meetings, at baseline and at three months after the beginning of the intervention. Anthropometric measurements and collection of blood samples will take place in each meeting. Demographic data and data on family and medical history, dietary habits, adherence to the Mediterranean diet, overall health status and physical activity will be collected at baseline. Participants will be provided with nutritional counselling and support both at the beginning and throughout the intervention. Participants will further report their monthly progress by completing online questionnaires (namely concerning their body weight, overall health status, physical activity and sleep quality), via use of an online assessment tool developed by our team. The effect of the intervention will be evaluated using anthropometric indices, body composition markers and biochemical biomarkers of cardiometabolic control, pre- and post- intervention. Gene-diet interactions will be assessed via genotyping of DNA samples and statistical analyses will take place via statistical packages, such as PLINK v.1.9.

NCT ID: NCT04697225 Completed - Clinical trials for Overweight and Obesity

Healthy Weight at Home: A Pilot Weight Loss Program for Parents of Children With a Disability

Start date: January 4, 2021
Phase: N/A
Study type: Interventional

The objective of this study is to design, implement, and pilot a lifestyle-based, 12-week, weight loss program for parents of children with a disability. This weight loss program supports weight loss among parents. It is a first step towards a parent-only approach to promote healthier weight among children with a disability.

NCT ID: NCT04686994 Completed - Clinical trials for Overweight and Obesity

Study to Evaluate the Safety and Efficacy of ASC41 in Overweight and Obese Subjects

Start date: December 22, 2020
Phase: Phase 1
Study type: Interventional

The primary objective of this study is to evaluate the safety, tolerability and compare the pharmacokinetic parameters of ASC41, a THR beta agonist tables in overweight and obese subjects who have elevated LDL-C .

NCT ID: NCT04686552 Completed - Clinical trials for Overweight and Obesity

Effect Cinnamon Spice on Postprandial Glucose and Insulin Responses

CINNI
Start date: January 1, 2018
Phase: N/A
Study type: Interventional

The objective of the proposed study is to investigate the effect of cinnamon on the postprandial glycemic response to a high glycemic index meal in normal and overweight/obese prediabetic subjects

NCT ID: NCT04677738 Completed - Obesity Clinical Trials

Investigation of the Effects of a Bifidobacterium Breve Strain on Fat Loss in Healthy Adults

Start date: August 20, 2020
Phase: N/A
Study type: Interventional

Overweight has become a critical issue in North America and the market value of weight loss products is expected to rise as the population becomes more health-conscious and aware of the risks associated with excess body weight. This randomized, placebo-controlled, clinical trial investigates the effect of Bifidobacterium breve supplementation with exercise intervention on fat loss.

NCT ID: NCT04647149 Completed - Obesity Clinical Trials

Effects of Early and Delayed Time-restricted Eating in Adults With Overweight and Obesity

Start date: September 3, 2019
Phase: N/A
Study type: Interventional

Time-restricted eating (TRE) is a dietary approach that aims to increase fasting time and decrease the eating window. Promising TRE effects on weight loss and some cardiometabolic risk factors have been reported. However, there is a lack of randomized clinical trials that directly investigate the effect of TRE at different times of the day (early vs. delayed) in individuals with overweight and obesity. The present study investigates the effects of 8 weeks of TRE performed at different moments of the day on body composition and cardiometabolic parameters in adults with overweight and obesity.

NCT ID: NCT04645108 Completed - Obesity Clinical Trials

Coached or Non-Coached Weight Loss Intervention

Start date: November 20, 2020
Phase: N/A
Study type: Interventional

To evaluate the effect of one-on-one coaching in the Noom Healthy Weight Program, a digital behavior change, weight loss intervention, compared to the same program with no coaching, as well as influential factors.